Company · London
Novartis Pharmaceuticals UK Limited
Manufacture of basic pharmaceutical products
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Novartis Pharmaceuticals UK Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 59
- Marie-Andree Renee Gamache 2022-2024 View profile
- Roland Kreissig 2021-2022 View profile
- Chinmay Umesh Bhatt 2020-2022 View profile
- Jason Mark Brooks 2019-2025 View profile
- Dr Anna Mari Scheiffele 2018-2021 View profile
- Barak Avraham Palachi 2017-2018 View profile
- Haseeb Ahmad 2017-2021 View profile
- Marie-France Tschudin 2017-2019 View profile
- Oriane Fanny Lacaze 2016-2019 View profile
- Christopher David Snook 2016-2017 View profile
- Hugh Michael O'Dowd 2015-2016 View profile
- Edgar Humberto Arrocha 2014-2016 View profile
- Harry Werner Kirsch 2013-2018 View profile
- Guido Angelo Giovanni Guidi 2013-2017 View profile
- Frederic Marcel Benoit Guerard 2012-2015 View profile
- Sandipkumar Shantilal Kapadia 2012-2014 View profile
- Jonathan Richard Symonds 2010-2013 View profile
- Susan Ann Webb 2009-2012 View profile
- Teresa Jose 2009-2012 View profile
- Lluis Prat 2007-2016 View profile
- Dr Eric Cornut 2007-2013 View profile
- Jean-Jacques Charhon 2006-2007 View profile
- Richard John Brazier 2006-2009 View profile
- Subhanu Saxena 2005-2009 View profile
- Dr Ludwig Norbert Michel Hantson 2005-2007 View profile
- Gordon John Cummins 2004-2006 View profile
- Michael John Fahey 2001-2004 View profile
- William Drummond Paris 2001-2005 View profile
- Silvio Gabriel 2001-2005 View profile
- David Thomas Ashton 2001-2001 View profile
- Dr Raymund Breu 2000-2010 View profile
- Reto Ernst Brandli 2000-2006 View profile
- Adrian Adams 1999-2001 View profile
- Joerg Reinhardt 1999-2005 View profile
- Stefan Hans Stroppel 1998-2001 View profile
- John Symon 1997-1999 View profile
- Hans Kindler 1997-2000 View profile
- James Clifford Youmans 1997-1997 View profile
- Edgar Fullagar 1997-2002 View profile
- Dr Martin Christopher Batzer 1995-1997 View profile
- Daniel Vasella 1995-1997 View profile
- Jacques Racloz 1994-1997 View profile
- Dr Urs Barlocher 1993-1995 View profile
- Eduard Gerhard Krops 1993-1993 View profile
- Richard Metcalfe 1993-1997 View profile
- Peter Schlienger 1992-1995 View profile
- Dr Erwin Schillinger 1992-1993 View profile
- Professor Humphrey Peter Rang 1992-1997 View profile
- Rene Wack 1992 View profile
- Max Link 1993 View profile
- Rolf Soiron 1993 View profile
- Timothy William Robinson 2022-2026 View profile
- Rebecca Ann Weston 2016-2021 View profile
- Benjamin James Michael Holgate 2011-2016 View profile
- Helen Roberts 2008-2011 View profile
- Sally Jane Jennings 2000-2008 View profile
- Sally Jane Shorthose 2000-2000 View profile
- Valerie Allsup 1997-2000 View profile
- Paul Richard Edward Thirkettle 1997 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
10 contracts · £15,809,352 totalFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack
Procurement of SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack
-
NHS National Generic Pharmaceuticals - Wave 16a
NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…
Framework -
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
CM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20…
Framework -
Oncology Generics Medicines
This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in secti…
Framework -
solution for infusion vial
1458 - Lutathera 7400MBq/20.5-25ml solution for infusion vials Purchase requisition number: RGTN30000850
-
NHS National Branded Interim - 1 June 2026
Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months
Framework -
TRAMETINIB 2MG TABLETS, 30 tablet, pack
Procurement of TRAMETINIB 2MG TABLETS, 30 tablet, pack
-
Transitional Drugs 7
The provision of Drugs that have recently lost exclusivity
-
Utathera 7400MBq/20.5-25ml solution
1529 - Utathera 7400MBq/20.5-25ml solution for infusion vials PR
-
REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet
Procurement of REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet
About
- What it does
- Manufacture of basic pharmaceutical products
- Incorporated
- 08/12/1911
- Registered office
- London
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Novartis UK Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06
Group
- Novartis Pharmaceuticals UK Limited
is controlled by Novartis UK Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Novartis UK Limited.
5 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
2 directors on the board
- Johan Mikael Olof Kahlstroem Director · appointed 2024
- Sandeep Gupta Director · appointed 2025
First-time vs portfolio directors
Portfolio (2)
- Johan Mikael Olof Kahlstroem Director · appointed 2024
- Sandeep Gupta Director · appointed 2025
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 00119006
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data